Skip to main content

Advertisement

Peer Review reports

From: The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients

Original Submission
11 Jul 2017 Submitted Original manuscript
18 Jul 2017 Author responded Author comments - Mary Jo Fidler
Resubmission - Version 2
18 Jul 2017 Submitted Manuscript version 2
21 Aug 2017 Reviewed Reviewer Report - Charles Butts
14 Sep 2017 Reviewed Reviewer Report - Melissa Johnson
22 Dec 2017 Author responded Author comments - Mary Jo Fidler
Resubmission - Version 3
22 Dec 2017 Submitted Manuscript version 3
8 Feb 2018 Reviewed Reviewer Report - Charles Butts
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
6 Mar 2018 Editorially accepted
20 Mar 2018 Article published 10.1186/s12885-018-4193-0

You can find further information about peer review here.

Back to article page